Eudaimonia Partners’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$217K	Buy	+6,732	New	+$217K	0.04%	355
2021 Q2	–	Sell	-521	Closed	-$16K	–	1006
2021 Q1	$16K	Buy	+521	New	+$16K	﹤0.01%	1017